ScholarIQanswers from OpenAlex
Amyloidosis: Diagnosis, Treatment, Outcomes
TopicLeading institutions, researchers & key papers
Amyloidosis: Diagnosis, Treatment, Outcomes is a topic indexed in ScholarIQ from OpenAlex.
What is known about Amyloidosis: Diagnosis, Treatment, Outcomes?
ScholarIQrecord summary
This cluster of papers focuses on the molecular mechanisms, diagnosis, treatment, and prognosis of amyloidosis, with a particular emphasis on transthyretin-related cardiac and familial amyloid polyneuropathy. It covers topics such as RNAi therapy, cardiovascular magnetic resonance, and immunoglobulin light chain involvement.
How many works does Amyloidosis: Diagnosis, Treatment, Outcomes have?
ScholarIQindexed works
Amyloidosis: Diagnosis, Treatment, Outcomes has 173 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Amyloidosis: Diagnosis, Treatment, Outcomes?
ScholarIQopenalex
The OpenAlex for Amyloidosis: Diagnosis, Treatment, Outcomes is on the source record.
What are the most-cited papers on Amyloidosis: Diagnosis, Treatment, Outcomes?
ScholarIQmost cited works
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
David Adams, Alejandra González‐Duarte, William O’Riordan, Chih‐Chao Yang, Mitsuharu Ueda, Arnt V. Kristen, Ivailo Tournev, Hartmut Schmidt, Teresa Coelho, John L. Berk, Kon-Ping Lin, Giuseppe Vita, Shahram Attarian, Violaine Planté‐Bordeneuve, Michelle M. Mezei, Josep M. Campistol, Juan Buades, Thomas H. Brannagan, Byoung J. Kim, Jeeyoung Oh, Yeşim Parman, Yoshiki Sekijima, Philip N. Hawkins, Scott D. Solomon, Michael Polydefkis, P. James B. Dyck, Pritesh J. Gandhi, Sunita Goyal, Jihong Chen, Andrew Strahs, Saraswathy V. Nochur, Marianne T. Sweetser, Pushkal Garg, Akshay Vaishnaw, Jared Gollob, Ole B. Suhr
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Matthew J. Maurer, Jeffrey H. Schwartz, Balarama Gundapaneni, Perry Elliott, Giampaolo Merlini, Márcia Waddington‐Cruz, Arnt V. Kristen, Martha Grogan, Ronald Witteles, Thibaud Damy, Brian Drachman, Sanjiv J. Shah, Mazen Hanna, Daniel P. Judge, Alexandra I. Barsdorf, Peter M. Huber, Terrell A. Patterson, Steve Riley, Jennifer Schumacher, Michelle Stewart, Marla B. Sultan, Claudio Rapezzi
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
Morie A. Gertz, Ray Comenzo, Rodney H. Falk, Jean Paul Fermand, Bouke P. C. Hazenberg, Philip N. Hawkins, Giampaolo Merlini, Philippe Moreau, Pierre Ronco, Vaishali Sanchorawala, Orhan Sezer, Alan Solomon, G Grateau
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
Mathew S. Maurer, Sabahat Bokhari, Thibaud Damy, Sharmila Dorbala, Brian Drachman, Marianna Fontana, Martha Grogan, Arnt V. Kristen, Isabelle Lousada, José Nativi-Nicolau, Candida Cristina Quarta, Claudio Rapezzi, Frederick L. Ruberg, Ronald Witteles, Giampaolo Merlini
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
Nelson Leung, Frank Bridoux, Vecihi Batuman, Aristeidis Chaidos, Paul Cockwell, Vivette D. D’Agati, Angela Dispenzieri, Fernando C. Fervenza, Jean-Paul Fermand, Simon Gibbs, Julian D. Gillmore, Guillermo A. Herrera, Arnaud Jaccard, Dragan Jevremović, Efstathios Kastritis, Vishal Kukreti, Robert A. Kyle, Helen J. Lachmann, Christopher P. Larsen, Heinz Ludwig, Glen S. Markowitz, Giampaolo Merlini, Peter Mollee, Maria M. Picken, S. Vincent Rajkumar, Virginie Royal, Paul W. Sanders, Sanjeev Sethi, Christopher P. Venner, Peter M. Voorhees, Ashutosh Wechalekar, Brendan M. Weiss, Samih H. Nasr
Where is Amyloidosis: Diagnosis, Treatment, Outcomes research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Amyloidosis: Diagnosis, Treatment, Outcomes is open access?
ScholarIQopen access share
80%OPEN ACCESS